These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22059786)

  • 21. Diuretics for cardiovascular prevention in the elderly.
    Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharm Pharmacol; 2009 Jan; 61(1):79-87. PubMed ID: 19126300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diltiazem: its place in the antihypertensive armamentarium.
    Fagan TC
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S26-31. PubMed ID: 1725539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy in the treatment of hypertension.
    Escobar C; Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins in hypertension: are they a new class of antihypertensive agents?
    Feldstein CA
    Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the efficacity and tolerance of diltiazem LP 300 mg in 2000 hypertensive patients (alone or combined with an angiotensin converting enzyme inhibitor].
    Amar J; Joire JE; Salvador M
    Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):69-75. PubMed ID: 12555361
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of diltiazem in treating hypertension and coronary artery disease: new approaches to preventing first events.
    Fodor JG; Boulet AP; Savard D; Nadeau C; Rakusan K; Chockalingam A; Langer A
    Can J Cardiol; 1997 May; 13(5):495-503. PubMed ID: 9179089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of diltiazem in the treatment of arterial hypertension in the elderly].
    Pêgo GM; De Carvalho MJ; D'Araújo JA; Ramalhão C; Da Silva PM
    Acta Med Port; 2000; 13(1-2):7-12. PubMed ID: 11059049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Melatonin in the combined treatment of cardiovascular diseases].
    Zaslavskaia RM; Shcherban' EA; Lilitsa GV; Logvinenko SI
    Klin Med (Mosk); 2010; 88(3):26-30. PubMed ID: 20608060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart, brain and hypertension].
    Lüscher TF; Sturzenegger M; Noll G
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Hypertension in Patients with Ischemic Heart Disease.
    Agbor-Etang BB; Setaro JF
    Curr Cardiol Rep; 2015 Dec; 17(12):119. PubMed ID: 26482762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.